Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.56 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 4/20 | 0.50 |
| ▸ | APP | P05067 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CES1 | P23141 | 5/20 | 0.45 |
| ▸ | CES2 | O00748 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL199732 | 1.00 | FAAH (0.56) | FAAHEPHX2CA2APPCA1 | |
| SCHEMBL22200 | 1.00 | FAAH (0.56) | FAAHEPHX2CA2APPCA1 | |
| SCHEMBL7520221 | 1.00 | FAAH (0.56) | FAAHEPHX2CA2APPCA1 | |
| SCHEMBL528580 | 1.00 | FAAH (0.56) | FAAHEPHX2CA2APPCA1 | |
| SCHEMBL150843 | 1.00 | FAAH (0.56) | FAAHEPHX2CA2APPCA1 | |
| SCHEMBL151083 | 1.00 | FAAH (0.56) | FAAHEPHX2CA2APPCA1 | |
| SCHEMBL304724 | 1.00 | FAAH (0.56) | FAAHEPHX2CA2APPCA1 | |
| SCHEMBL496699 | 1.00 | FAAH (0.56) | FAAHEPHX2CA2APPCA1 | |
| SCHEMBL22608765 | 1.00 | FAAH (0.56) | FAAHEPHX2CA2APPCA1 | |
| SCHEMBL77271 | 1.00 | FAAH (0.56) | FAAHEPHX2CA2APPCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011027248-A1 | ORAL LIQUID FORMULATION COMPRISING SALBUTAMOL AND GUAIFENESIN | VANANGAMUDI SULUR SUBRAMANIAM (IN) | 2011-03-10 | — | — | WO | disclosed |